Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Margolis

Showing results (711-720 of 732) with videos related to

Pageof 74
Sort By:
Journal of the American Academy of Dermatology|May 13, 2014
Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapiesLawrence F Eichenfield, Wynnis L Tom, Timothy G Berger, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Discovery of non-covalent dipeptidyl peptidase IV inhibitors which induce a conformational change in the active siteScott M Sheehan, Hans-Juergen Mest, Brian M Watson, et al.
Journal of the American Academy of Dermatology|December 3, 2013
Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitisLawrence F Eichenfield, Wynnis L Tom, Sarah L Chamlin, et al.
Journal of Medicinal Chemistry|October 27, 2017
Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft ModelKevin R Fales, F George Njoroge, Harold B Brooks, et al.
JAMA|May 4, 2016
Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011Katherine E Fleming-Dutra, Adam L Hersh, Daniel J Shapiro, et al.
The Journal of Investigative Dermatology|March 22, 2003
Stroma formation and angiogenesis by overexpression of growth factors, cytokines, and proteolytic enzymes in human skin grafted to SCID miceClaus J Gruss, Kapaettu Satyamoorthy, Carola Berking, et al.
Science Translational Medicine|February 28, 2020
Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitisMadison R Mack, Jonathan R Brestoff, Melissa M Berrien-Elliott, et al.
JAMA Dermatology|March 7, 2019
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10Megan H Noe, Misha Rosenbach, Rebecca A Hubbard, et al.
Oncotarget|October 19, 2018
Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigationSonia Gaur, Nathan Lay, Stephanie A Harmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2020
Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO GuidelineEdouard J Trabulsi, R Bryan Rumble, Hossein Jadvar, et al.
Pageof 74

Showing results (711-720 of 732) with videos related to

Sort By:
Pageof 74
Journal of the American Academy of Dermatology|May 13, 2014
Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapiesLawrence F Eichenfield, Wynnis L Tom, Timothy G Berger, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Discovery of non-covalent dipeptidyl peptidase IV inhibitors which induce a conformational change in the active siteScott M Sheehan, Hans-Juergen Mest, Brian M Watson, et al.
Journal of the American Academy of Dermatology|December 3, 2013
Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitisLawrence F Eichenfield, Wynnis L Tom, Sarah L Chamlin, et al.
Journal of Medicinal Chemistry|October 27, 2017
Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft ModelKevin R Fales, F George Njoroge, Harold B Brooks, et al.
JAMA|May 4, 2016
Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011Katherine E Fleming-Dutra, Adam L Hersh, Daniel J Shapiro, et al.
The Journal of Investigative Dermatology|March 22, 2003
Stroma formation and angiogenesis by overexpression of growth factors, cytokines, and proteolytic enzymes in human skin grafted to SCID miceClaus J Gruss, Kapaettu Satyamoorthy, Carola Berking, et al.
Science Translational Medicine|February 28, 2020
Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitisMadison R Mack, Jonathan R Brestoff, Melissa M Berrien-Elliott, et al.
JAMA Dermatology|March 7, 2019
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10Megan H Noe, Misha Rosenbach, Rebecca A Hubbard, et al.
Oncotarget|October 19, 2018
Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigationSonia Gaur, Nathan Lay, Stephanie A Harmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2020
Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO GuidelineEdouard J Trabulsi, R Bryan Rumble, Hossein Jadvar, et al.
Pageof 74